Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Head and Neck, and Prostate Cancers

Prostate Cancer Clinical Trial

Official title:

Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Head and Neck, and Prostate Cancers

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01535898
• Other study ID #: 12-033
• Status: Completed
• Phase: N/A
• First received: February 13, 2012
• Last updated: May 4, 2017
• Start date: February 2012
• Est. completion date: February 2015

Study information

• Verified date: May 2017
• Source: Memorial Sloan Kettering Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Magnetic resonance imaging (MRI) is a diagnostic study that makes pictures of organs of the body using magnetic field and radio frequency pulses that can not be felt. The purpose of this study is to determine if a new MR imaging method can help tumor evaluation in head and neck cancer or prostate cancer. The extra images will be obtained using Diffusion-weighted Magnetic Resonance Imaging which provides image contrast through detection of small restrictions in the movement of water molecules. This study may help us provide additional information about the tumor along with the picture of the organ.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 10
• Est. completion date: February 2015
• Est. primary completion date: February 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Adults aged 18 and over.

• Men and women without regard to ethnic background.

• Patients/Subjects able to give informed consent

• Patients/Subjects whose weight does not exceed 275 lbs.

• Patient with a known or suspected head and neck cancer or prostate cancer scheduled for an MRI scan as part of their routine care --OR--

• Volunteer with no history of the disease in that category.

Exclusion Criteria:

• Patients who are unwilling or unable to undergo MRI including patients with contra-indications to MRI such as the presence of cardiac pacemakers or non-compatible intracranial vascular clips.

Related Conditions & MeSH terms

• Body Weight
• Head and Neck Cancer
• Head and Neck Neoplasms
• Prostate Cancer
• Prostatic Neoplasms

Intervention

Other:
• MRI scanner with sequence
The intervention for the patients is the additional 10 minutes in the MRI scanner with sequence. The intervention for the volunteers is the scan, which will take a total of 30 minutes. The volunteers will have two more additional studies at 1-2 week intervals. Both the patients and volunteers will also need to fill out a questionnaire.

Locations

Country	Name	City	State
United States	Memorial Sloan Kettering Cancer Center	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
Memorial Sloan Kettering Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	feasibility of high resolution diffusion-weighted imaging	using a new DWI pulse sequence from the manufacturer (General Electric Medical Systems (Milwaukee, WI)) for the assessment of head and neck cancer cancer and prostate cancer.	2 years

External Links

•   Memorial Sloan Kettering Cancer Center